Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Archives of Pathology & Laboratory Medicine|July 31, 2010
Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literatureNicky Leeborg, Michele Thompson, Sarah Rossmiller, et al.
American Journal of Clinical Pathology|October 21, 2010
Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoidesKatalin Kelemen, Clifton R White, Ken Gatter, et al.
American Journal of Hematology|February 24, 2004
Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantationBrandon Hayes-Lattin, Timothy J Seipel, Ken Gatter, et al.
Pediatric Dermatology|January 22, 2005
Spontaneous regression of aleukemia congenital leukemia cutisMaeran C Landers, Suman Malempati, David Tilford, et al.
American Journal of Clinical Pathology|May 19, 2005
Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometryJames Huang, Guang Fan, Yanping Zhong, et al.
American Journal of Clinical Pathology|June 17, 2010
Immunophenotypic variations of Burkitt lymphomaKatalin Kelemen, Rita M Braziel, Ken Gatter, et al.
American Journal of Clinical Pathology|July 18, 2015
The New Equivocal: Changes to HER2 FISH Results When Applying the 2013 ASCO/CAP GuidelinesThomas H Long, Helen Lawce, Connie Durum, et al.
American Journal of Clinical Pathology|April 20, 2011
Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasmsJennifer Dunlap, Katalin Kelemen, Nicky Leeborg, et al.
The Journal of Molecular Diagnostics : JMD|October 27, 2006
Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemiaChristopher L Corless, Patina Harrell, Mario Lacouture, et al.
Leukemia & Lymphoma|September 5, 2017
MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypesPhilipp W Raess, Stephen R Moore, Michael J Cascio, et al.
Pageof 2